Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice ; volume:10 ; number:1 ; day:16 ; month:7 ; year:2019 ; pages:1-13 ; date:12.2019
Stem cell research & therapy ; 10, Heft 1 (16.7.2019), 1-13, 12.2019
- Urheber
-
Kuroshima, Shinichiro
Nakajima, Kazunori
Sasaki, Muneteru
I, Takashi
Sumita, Yoshinori
Asahara, Takayuki
Asahina, Izumi
Sawase, Takashi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-019-1308-8
- URN
-
urn:nbn:de:101:1-2019120903194642965999
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuroshima, Shinichiro
- Nakajima, Kazunori
- Sasaki, Muneteru
- I, Takashi
- Sumita, Yoshinori
- Asahara, Takayuki
- Asahina, Izumi
- Sawase, Takashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats
Bisphosphonate related osteonecrosis of the jaws: An update
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats
Bisphosphonate related osteonecrosis of the jaws: An update
Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
Bisphosphonate-Related Osteonecrosis of the Jaw: An Enigma among Medical Practitioners
Significance of medication discontinuation on bisphosphonate-related jaw osteonecrosis in a rat model
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw
Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients’ Gingiva
Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features
Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw
Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats